Eupraxia Pharmaceuticals Establishes $125M At-The-Market Offering Program
Eupraxia Pharmaceuticals Inc. announced the establishment of an at-the-market equity program (ATM Program) allowing for the sale of up to US$125 million in common shares. The company stated that this is a general corporate housekeeping measure and they have no current plans to utilize the program, as their existing cash reserves are sufficient until the second half of 2028. The program is being implemented through sales agreements with Jefferies LLC and Jefferies Securities, Inc.
Key Highlights
- Eupraxia Pharmaceuticals Inc. established an at-the-market equity program (ATM Program).
- The ATM Program allows for the offering and sale of up to US$125 million of common shares.
- The Company has no current plan to use the ATM Program in the near term.
- Current cash balances are sufficient to cover planned expenses until H2 2028.
- The ATM Program is a general corporate housekeeping item, consistent with industry norms.
Price Impact
More from EPRX
Eupraxia Pharmaceuticals to Sell Up to $300M in Common Shares via Agents Agreement
Eupraxia Pharmaceuticals Reaches EoE Trial Enrollment; Q3 Loss $15.2M
Eupraxia Pharmaceuticals to Present EoE Trial Data at ACG and UEG Conferences